Genentech's company policy, Herbert Boyer
Interviewee: Herbert Boyer. Herb Boyer talks about his and Bob Swanson's vision on combining the best of academia, industry and business. (DNAi Location: Manipulation > Production > Players > Herbert Boyer >The company policy.)
We've got to hire young people that have the enthusiasm and energy and we, most importantly we have to give them the right to publish what they do. And Bob had, he was a little recalcitrant about that part of it, and so we finally worked out a policy where we'll have patent attorneys and as soon as somebody has something and it's going to be published they've got to get the patent done, they can't take two years and keep this work, you know, under wraps. And I thought that was very important for attracting talented young scientists and it would give them peer recognition. One of the problems I had with the traditional pharmaceutical industry was that I didn't know the scientists in these firms, you didn't read about what they did, there was some publications but they weren't part of the scientific community.
herbert boyer,bob swanson,patent attorneys,academia industry,young scientists,dnai,s vision,genentech,interviewee,pharmaceutical industry,wraps,manipulation
Tour of Genentech by David Ebersman
Herb Boyer talks about how the first biotech company got its name.
Herb Boyer talks about the fateful meeting, which led to the establishment of the first biotech company.
In 1980, Genentech became the first publicly traded biotech company. David Goeddel talks about his investment.
David Goeddel was one of the first scientists Herb Boyer hired for the insulin project. Here, David Goeddel talks about Genentech's general strategy for synthesizing insulin.
Herb Boyer reflects on his initial investment in Genentech.
Herb Boyer and Stan Cohen "invented" recombinant DNA technology.
Herbert Boyer, cofounder of Genentech, Inc.
Herb Boyer talks about Stanley Cohen's and his interest in plasmids as vectors for DNA.
Herb Boyer reflects on the importance of their work on rDNA technology and its impact on understanding the genetics of higher organisms.